Therefore, beyond angiogenesis, VEGFR-2 activity might extend to the promotion of vascularization through other pathways, highlighting its multifaceted role in PC progression and presenting opportunities for combination therapeutic intervention to curtail metastasis. Here, KDR is linked to pachyonychia congenita.